Efficacy and safety results of telotristat ethyl in patients With carcinoid syndrome during the double-blind treatment period of the TELECAST phase 3 clinical trial.
Authors
Pavel, MGross, D
Benavent, M
Caplin, M
Perros, P
Srirajaskanthan, R
Valle, Juan W
Warner, R
Kulke, M
Anthony, L
Kunz, P
Horsch, D
Berg, K
Lapuerta, P
Jackson, S
Banks, P
Biran, T
Garcia-Carbonero, R
Affiliation
Charité-Universitätsmedizin Berlin, CVK, Med. Klinik m. SchwerpunktIssue Date
2017